Access restrictions apply.Some or all content stored offsite.
| Container | Contents | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Part I: Research File, 1917-1998 (continued) | |||||||||||||
| Merital, 1986-1990 (continued) | |||||||||||||
| (2 folders) | |||||||||||||
| BOX I:22 | Methotrexate, 1961 | ||||||||||||
| BOX I:22 | Miscellany, 1963-1996, undated | ||||||||||||
| BOX I:22 | MK 665 (Drug), 1966 | ||||||||||||
| BOX I:22 | Monase, 1960-1963, undated | ||||||||||||
| BOX I:22 | Myosed, 1961-1962, undated | ||||||||||||
| BOX I:22 | National Center for Drugs and Biologics, U.S. Food and Drug Administration, 1972, 1983-1984 | ||||||||||||
| BOX I:22 | National Library of Medicine, Bethesda, Md., computerization of scientific information, 1961-1964 | ||||||||||||
| BOX I:22 | New drug applications (NDAs), U.S. Food and Drug Administration | ||||||||||||
| BOX I:22 | Logs, 1957-1961 | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:23 | Reviews, 1963 | ||||||||||||
| BOX I:23 | New Drug Branch, U.S. Food and Drug Administration, 1960 | ||||||||||||
| BOX I:23 | Nicotinamide adenine dinucleotide (NAD), 1966-1968, 1989 | ||||||||||||
| BOX I:23 | Nitrogen mustards, undated | ||||||||||||
| BOX I:23 | Nobrium, 1956-1962, undated | ||||||||||||
| BOX I:23 | Norlutin, 1961, undated | ||||||||||||
| BOX I:23 | Ocular Drug Toxicities Symposium, Bethesda, Md., 1966-1971 | ||||||||||||
| BOX I:23 | Orphan drugs, 1977-1992 | ||||||||||||
| BOX I:23 | Parotin, 1963 | ||||||||||||
| BOX I:23 | Patient package inserts, 1969-1990, undated | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:23 | Potassium thiazide, 1964-1965, undated | ||||||||||||
| BOX I:23 | Practolol, 1980 | ||||||||||||
| BOX I:23 | Preludin, 1957-1962, undated | ||||||||||||
| BOX I:23 | Prescribing authority for pharmacists, 1983 | ||||||||||||
| BOX I:23 | Prescription drug labeling, 1969-1990, undated | ||||||||||||
| BOX I:23 | Procaine with polyvinylpyrrolidone (PVP) | ||||||||||||
| BOX I:23 | 1964-1980 | ||||||||||||
| BOX I:24 | 1983-1986, undated | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:24 | Prodilidine, 1961-1962, undated | ||||||||||||
| BOX I:24 | Progonasyl, 1971-1973 | ||||||||||||
| BOX I:24 | Propoquin, 1962, undated | ||||||||||||
| BOX I:24 | Quackery | ||||||||||||
| BOX I:24 | 1954-1988 | ||||||||||||
| (4 folders) | |||||||||||||
| BOX I:25 | 1989-1992, undated | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:25 | Radiochromate injection, 1961, undated | ||||||||||||
| BOX I:25 | Radio-rose bengal, 1961-1962, undated | ||||||||||||
| BOX I:25 | Ramps (Campanula rapunculus), 1969-1977 | ||||||||||||
| BOX I:25 | Rand cancer vaccine, 1966-1967 | ||||||||||||
| BOX I:25 | Rectalad, undated | ||||||||||||
| BOX I:25 | Reports | ||||||||||||
| BOX I:25 | Annual reports, Center for the Study of Drug Development, 1985-1987 | ||||||||||||
| BOX I:25 | Checks and balances in the practice of medicine and pharmacy: issues in prescribing and dispensing drugs, Medicine In the Public Interest, 1988 | ||||||||||||
| BOX I:26 | Commissioner's report of investigation of charges, joint hearings, Subcommittee on Health, Labor and Public Welfare Committee; Subcommittee on Administrative Practice and Procedure, Judiciary Committee, U.S. Senate (15-16 August 1974), 1975 | ||||||||||||
| BOX I:26 | Drug efficacy study, National Academy of Sciences, 1969 | ||||||||||||
| BOX I:26 | Drug information for the biomedical community: a report of a preliminary study of the needs for a national drug information clearinghouse, Institute for Advancement of Medical Communication, 1963 | ||||||||||||
| BOX I:26 | An experiment in early post-marketing surveillance of drugs, IMS America, 1978 | ||||||||||||
| BOX I:26 | Final report of the Tuskegee syphilis study ad hoc advisory panel, Department of Health, Education, and Welfare, 1973 | ||||||||||||
| BOX I:26 | Findings and recommendations of the review panel on new drug regulation, Commissioner of Food and Drugs, 1978 | ||||||||||||
| BOX I:27 | Maximizing the benefits of antibiotics, Medicine In the Public Interest, 1986 | ||||||||||||
| BOX I:27 | Medical dark ages circa 1984 or cancer alternative therapies' cure rates, Ralph R. Hovnanian, 1984 | ||||||||||||
| BOX I:27 | Miscellany, 1959-1964 | ||||||||||||
| BOX I:27 | Post-approval pharmaceutical research and development, Medicine In the Public Interest, 1988 | ||||||||||||
| BOX I:27 | Prescription drug information for patients and direct-to-consumer advertising, Medicine In the Public Interest, 1984 | ||||||||||||
| BOX I:27 | Report on the conference on clinical pharmacology, National Academy of Sciences, 1971 | ||||||||||||
| BOX I:27 | Review of studies of the effect induced in animals and man by the administration of the nonnutritive sweetening agent saccharin, Bureau of Science-Bureau of Medicine, 1970 | ||||||||||||
| BOX I:27 | Therapeutic substitution symposium, Medicine In the Public Interest, 1986 | ||||||||||||
| BOX I:27 | Revici, Emanuel, controversy regarding clinical investigation of selenium diethyl dithiocarbonate (SDD) as a treatment for cancer, 1989-1996, undated | ||||||||||||
| BOX I:27 | Ritalin, 1958-1961, undated | ||||||||||||
| BOX I:27 | Rutherford v. United States, deposition of Kelsey regarding cancer treatment, 1977 | ||||||||||||
| BOX I:27 | Secozole, 1962 | ||||||||||||
| BOX I:27 | Shoe-fitting fluoroscopes, 1949-1969, undated | ||||||||||||
| BOX I:27 | Silicone injection, 1966-1975 | ||||||||||||
| BOX I:27 | Somnafac, 1961-1963, undated | ||||||||||||
| BOX I:27 | Strilexate, 1961-1962, undated | ||||||||||||
| BOX I:28 | Subacute myelo-optico-neuropathy (SMON), 1978-1984 (2 folders) | ||||||||||||
| BOX I:28 | Subject studies in vulnerable populations | ||||||||||||
| BOX I:28 | Fetuses, infants, and children, 1961-1991, undated | ||||||||||||
| (3 folders) | |||||||||||||
| BOX I:28 | Geriatrics | ||||||||||||
| BOX I:28 | 1959-1980 | ||||||||||||
| BOX I:29 | 1981-1993, undated | ||||||||||||
| (4 folders) | |||||||||||||
| BOX I:29 | Prisoners | ||||||||||||
| BOX I:29 | 1963-1973 | ||||||||||||
| (3 folders) | |||||||||||||
| BOX I:30 | 1974-1980 | ||||||||||||
| (8 folders) | |||||||||||||
| BOX I:30 | Undated | ||||||||||||
| (1 folder) | |||||||||||||
| BOX I:31 | (1 folder) | ||||||||||||
| BOX I:31 | Women of childbearing potential, 1972-1993 | ||||||||||||
| BOX I:31 | Summers, William K., controversy regarding clinical investigation of tetrahydroaminoacridine (THA) (Tacrine), as a treatment for Alzheimer's disease | ||||||||||||
| BOX I:31 | Alzheimer's disease, 1978-1994, undated | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:31 | Clinical investigation, 1985-1989 | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:31 | Correspondence regarding Summers, 1987-1992, undated | ||||||||||||
| BOX I:31 | Correspondence with Summers | ||||||||||||
| BOX I:31 | 1986-1987 | ||||||||||||
| BOX I:32 | 1988-1992, undated | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:32 | Suprofen, 1986-1989 | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:32 | Teratology studies guidelines, 1982 | ||||||||||||
| BOX I:32 | Thalidomide | ||||||||||||
| BOX I:32 | Animal studies, 1962-1984, undated | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:32 | Bibliography, 1961-1973, undated | ||||||||||||
| BOX I:33 | Foreign government reports, 1961-1976, undated | ||||||||||||
| BOX I:33 | Investigations by Bureau of Field Administration, 1962-1969, 1994 | ||||||||||||
| BOX I:33 | Kevadon literature, 1960-1966, 1986-1987, undated | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:33 | Kühne's theory on leprosy (Paul Kühne), 1964-1994, undated | ||||||||||||
| BOX I:33 | London Times, article of 27 June 1976, 1962-1976, undated | ||||||||||||
| BOX I:33 | Lutwak-Mann on effects in males (Cecilia Lutwak-Mann), 1960-1964, 1994, undated | ||||||||||||
| BOX I:33 | Medical Tribune, 1962-1964, undated | ||||||||||||
| BOX I:34 | Miscellany, 1960-1994, undated | ||||||||||||
| (6 folders) | |||||||||||||
| BOX I:34 | Pharmaceutical industry reports, 1961-1963, undated | ||||||||||||
| BOX I:34 | Pharmaceutical industry's opposition to "Drug Industry Act of 1962," 1962 | ||||||||||||
| BOX I:34 | Subcommittee on Administrative Practice and Procedure, Senate Judiciary Committee, 1962-1965 | ||||||||||||
| BOX I:35 | Sievers, G., "Clinical, Statistical Studies on Teratologic Problems of Current Interest," 1964 | ||||||||||||
| BOX I:35 | Various therapeutic uses, 1963-1989, undated | ||||||||||||
| BOX I:35 | Triamcinolone diacetate (Aristocorte Forte and Aristocorte Parenteral), 1961-1962, undated | ||||||||||||
| BOX I:35 | Triparanol (MER-29), 1961-1962, 1980 | ||||||||||||
| BOX I:35 | Trisoralen, 1960-1962, undated | ||||||||||||
| BOX I:35 | Turkel, Henry, controversy regarding U.S. Food and Drug Administration's refusal to approve new drug application for "U" series drugs, 1968-1969 | ||||||||||||
| BOX I:35 | University Group Diabetes Program, 1972-1978, undated | ||||||||||||
| BOX I:35 | Vesprin, 1961-1962, undated | ||||||||||||
| BOX I:35 | Voices 12/60, educational audiocassette on teratogenicity of drugs, American Society of Hospital Pharmacists, with Kelsey et al. speaking, 1976-1977 | ||||||||||||
| Next Page » | |||||||||||||